-
Med. Clin. North Am. · Mar 2025
ReviewAlzheimer's Disease Diagnosis and Management in the Age of Amyloid Monoclonal Antibodies.
- Chadwick M Hales.
- Department of Neurology, Center for Neurodegenerative Disease, Goizueta Alzheimer's Disease Research Center, Emory University School of Medicine, 6 Executive Park Drive, Atlanta, GA 30329, USA. Electronic address: cmhales@emory.edu.
- Med. Clin. North Am. 2025 Mar 1; 109 (2): 463483463-483.
AbstractAlzheimer's disease (AD) is the most common neurodegenerative disorder, and for providers the term AD is often avoided, favoring generic terms like memory loss or dementia. This is partly not only by limitations in using diagnostics and busy clinics but also by a sense that an AD diagnosis will not lead to a meaningful change in management. However, a turning point has occurred with advancements in diagnostics and disease-modifying therapies. Additionally, AD prevention therapies are not too far into the future. This review will cover AD clinical presentation and symptomatic management with focus on AD diagnostics and disease-modifying therapies.Copyright © 2024 Elsevier Inc. All rights reserved.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..